RNAP II CTD tyrosine 1 performs diverse functions in vertebrate cells

  1. Jing-Ping Hsin
  2. Wencheng Li
  3. Mainul Hoque
  4. Bin Tian
  5. James L Manley  Is a corresponding author
  1. Columbia University, United States
  2. Rutgers University New Jersey Medical School, United States

Abstract

The RNA polymerase II largest subunit (Rpb1) contains a unique C-terminal domain (CTD) that plays multiple roles during transcription. The CTD is composed of consensus Y1S2P3T4S5P6S7 repeats, in which Ser, Thr and Tyr residues can all be phosphorylated. Here we report analysis of CTD Tyr1 using genetically tractable chicken DT40 cells. Cells expressing an Rpb1 derivative with all Tyr residues mutated to Phe (Rpb1-Y1F) were inviable. Remarkably, Rpb1-Y1F was unstable, degraded to a CTD-less form; however stability, but not cell viability, was fully rescued by restoration of a single C-terminal Tyr (Rpb1-25F+Y). Cytoplasmic and nucleoplasmic Rpb1 was phosphorylated exclusively on Tyr1, and phosphorylation specifically of Tyr1 prevented CTD degradation by the proteasome in vitro. Tyr1 phosphorylation was also detected on chromatin-associated, hyperphosphorylated Rpb1, consistent with a role in transcription. Indeed, we detected accumulation of upstream antisense (ua) RNAs in Rpb1-25F+Y cells, indicating a role for Tyr1 in uaRNA expression.

Article and author information

Author details

  1. Jing-Ping Hsin

    Columbia University, New York, United States
    Competing interests
    No competing interests declared.
  2. Wencheng Li

    Rutgers University New Jersey Medical School, Newark, United States
    Competing interests
    No competing interests declared.
  3. Mainul Hoque

    Rutgers University New Jersey Medical School, Newark, United States
    Competing interests
    No competing interests declared.
  4. Bin Tian

    Rutgers University New Jersey Medical School, Newark, United States
    Competing interests
    No competing interests declared.
  5. James L Manley

    Columbia University, New York, United States
    For correspondence
    jlm2@columbia.edu
    Competing interests
    James L Manley, Senior Editor, eLife.

Reviewing Editor

  1. Danny Reinberg, HHMI / NYU School of Medicine, United States

Version history

  1. Received: December 18, 2013
  2. Accepted: May 6, 2014
  3. Accepted Manuscript published: May 8, 2014 (version 1)
  4. Version of Record published: June 3, 2014 (version 2)

Copyright

© 2014, Hsin et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,779
    views
  • 279
    downloads
  • 40
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jing-Ping Hsin
  2. Wencheng Li
  3. Mainul Hoque
  4. Bin Tian
  5. James L Manley
(2014)
RNAP II CTD tyrosine 1 performs diverse functions in vertebrate cells
eLife 3:e02112.
https://doi.org/10.7554/eLife.02112

Share this article

https://doi.org/10.7554/eLife.02112

Further reading

    1. Biochemistry and Chemical Biology
    Kristian Davidsen, Lucas B Sullivan
    Research Article

    Current methods to quantify the fraction of aminoacylated tRNAs, also known as the tRNA charge, are limited by issues with either low throughput, precision, and/or accuracy. Here, we present an optimized charge transfer RNA sequencing (tRNA-Seq) method that combines previous developments with newly described approaches to establish a protocol for precise and accurate tRNA charge measurements. We verify that this protocol provides robust quantification of tRNA aminoacylation and we provide an end-to-end method that scales to hundreds of samples including software for data processing. Additionally, we show that this method supports measurements of relative tRNA expression levels and can be used to infer tRNA modifications through reverse transcription misincorporations, thereby supporting multipurpose applications in tRNA biology.

    1. Biochemistry and Chemical Biology
    2. Plant Biology
    Henning Mühlenbeck, Yuko Tsutsui ... Cyril Zipfel
    Research Article

    Transmembrane signaling by plant receptor kinases (RKs) has long been thought to involve reciprocal trans-phosphorylation of their intracellular kinase domains. The fact that many of these are pseudokinase domains, however, suggests that additional mechanisms must govern RK signaling activation. Non-catalytic signaling mechanisms of protein kinase domains have been described in metazoans, but information is scarce for plants. Recently, a non-catalytic function was reported for the leucine-rich repeat (LRR)-RK subfamily XIIa member EFR (elongation factor Tu receptor) and phosphorylation-dependent conformational changes were proposed to regulate signaling of RKs with non-RD kinase domains. Here, using EFR as a model, we describe a non-catalytic activation mechanism for LRR-RKs with non-RD kinase domains. EFR is an active kinase, but a kinase-dead variant retains the ability to enhance catalytic activity of its co-receptor kinase BAK1/SERK3 (brassinosteroid insensitive 1-associated kinase 1/somatic embryogenesis receptor kinase 3). Applying hydrogen-deuterium exchange mass spectrometry (HDX-MS) analysis and designing homology-based intragenic suppressor mutations, we provide evidence that the EFR kinase domain must adopt its active conformation in order to activate BAK1 allosterically, likely by supporting αC-helix positioning in BAK1. Our results suggest a conformational toggle model for signaling, in which BAK1 first phosphorylates EFR in the activation loop to stabilize its active conformation, allowing EFR in turn to allosterically activate BAK1.